CN108056469A - The preparation method of seaweed ferment with function of blood sugar reduction - Google Patents
The preparation method of seaweed ferment with function of blood sugar reduction Download PDFInfo
- Publication number
- CN108056469A CN108056469A CN201711216454.2A CN201711216454A CN108056469A CN 108056469 A CN108056469 A CN 108056469A CN 201711216454 A CN201711216454 A CN 201711216454A CN 108056469 A CN108056469 A CN 108056469A
- Authority
- CN
- China
- Prior art keywords
- seaweed
- blood sugar
- ferment
- function
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001474374 Blennius Species 0.000 title claims abstract description 63
- 239000008280 blood Substances 0.000 title claims abstract description 43
- 210000004369 blood Anatomy 0.000 title claims abstract description 43
- 230000009467 reduction Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 238000000855 fermentation Methods 0.000 claims abstract description 33
- 230000004151 fermentation Effects 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 8
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 7
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 6
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 6
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 6
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 244000241872 Lycium chinense Species 0.000 claims abstract description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 6
- 240000000920 Typhonium flagelliforme Species 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 6
- 238000005292 vacuum distillation Methods 0.000 claims abstract description 5
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000002002 slurry Substances 0.000 claims description 13
- 241000235342 Saccharomycetes Species 0.000 claims description 10
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000009928 pasteurization Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 239000010977 jade Substances 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000011651 chromium Substances 0.000 abstract description 13
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 6
- 229930091371 Fructose Natural products 0.000 abstract description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract description 5
- 239000005715 Fructose Substances 0.000 abstract description 5
- 102000004407 Lactalbumin Human genes 0.000 abstract description 5
- 108090000942 Lactalbumin Proteins 0.000 abstract description 5
- 240000008042 Zea mays Species 0.000 abstract description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract description 5
- 235000005822 corn Nutrition 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 229920001542 oligosaccharide Polymers 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 abstract description 4
- 239000000845 maltitol Substances 0.000 abstract description 4
- 229940035436 maltitol Drugs 0.000 abstract description 4
- 235000010449 maltitol Nutrition 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000003472 antidiabetic agent Substances 0.000 abstract description 2
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 230000001629 suppression Effects 0.000 abstract description 2
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- OZKRURPNXOGYGD-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1 OZKRURPNXOGYGD-UHFFFAOYSA-N 0.000 abstract 1
- 239000011669 selenium Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 5
- 229910052804 chromium Inorganic materials 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 229940046374 chromium picolinate Drugs 0.000 description 3
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to food ferment fields, and in particular to a kind of seaweed ferment with function of blood sugar reduction and preparation method thereof.Seaweed ferment provided by the present invention is to be prepared with seaweed, ginseng, pueraria lobata, the fruit of Chinese wolfberry, ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, corn stigma etc. for raw material.The present invention adds in lactobacillus plantarum, Lactobacillus rhamnosus and streptococcus thermophilus after pretreatment of raw material and carries out one time fermentation;It adds in Cr-enriched yeast and Se-enriched yeast carries out secondary fermentation.Vacuum distillation removes alcohol and compounds cell-oligosaccharide, fructose, maltitol, pyridine carboxylic acid chromium as hypoglycemic suppression fat, VC, VE, lactalbumin, and after-ripening obtains the final seaweed ferment with function of blood sugar reduction.Toxic side effect The present invention reduces drug enhances antidiabetic function, improves fermentation efficiency, improves immunity of organisms, after-ripening compounded formula adjustment flavor, improves mouthfeel, is formed a kind of with effect of lowering blood sugar and the excellent enzyme beverage of mouthfeel.
Description
Technical field
The invention belongs to food fermentation technical fields, and in particular to a kind of preparation of the seaweed ferment with function of blood sugar reduction
Method.
Background technology
The in vivo metabolism of organism is promoted by ferment and shows a variety of vital movements.Ferment is metabolic in human body
Catalyst plays an important role of to adjust vivo environment, bactericidal antiphlogistic, balance blood sugar blood fat, purification blood, only activating cell, ferment
Element exists, and every biochemical reaction could be carried out in human body.With advancing age, the in vivo ferment content of people reduces, body generation
It thanks to rate decline, the trend of aging is presented.Human diseases, it is most of related with ferment shortage or dyssynthesis.Supplement ferment
Element can improve the immunity function of people, make internal indices at equilibrium, and effectively prevention includes two type glycosurias
A variety of diseases including disease improve acid system and inferior health.
Seaweed has very high economic value and medical value, good protein and unrighted acid in seaweed, right
Heart disease, diabetes, hypertension have certain preventive and therapeutic effect.Main component-the food fiber for forming alginic cell wall is that have
The macromolecular of polysaccharide class formation, while be also distributed about in space between cells.Algal polysaccharides have a variety of physiological activity, as anticoagulation,
Hypoglycemic, reducing blood lipid and strengthen immunity etc. are widely used in food, medicine and other fields.Algal polysaccharides are as a kind of day
Right polymeric carbohydrate has remarkable result and advantage in terms of control blood glucose and its chronic complicating diseases.
The production method of existing ferment is mostly spontaneous fermentation, is completed by the automatic adjustment mode of organism, is consumed
Duration, metabolite is single, and easily generates miscellaneous bacteria.With the development of innovation and the research of science and technology, the production of seaweed ferment
The adjustment and improvement of technique and preparation method would be more advantageous to be furtherd investigate in it.
The content of the invention
In order to solve the technical issues of above-mentioned, the present invention provides a kind of preparations of the seaweed ferment with function of blood sugar reduction
Method.
The raw material of seaweed ferment provided by the present invention mainly includes raw material and complex microorganism with effect of lowering blood sugar.
The primary raw material of the present invention is seaweed and other raw materials with effect of lowering blood sugar, including:Ginseng, pueraria lobata, matrimony vine
Son, ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, corn stigma etc..Empirical tests, the raw material cooperation of these integration of drinking and medicinal herbs are made
Ferment compared with single raw material, hypoglycemic effect is more preferably.
Preferably, seaweed is 60~70 parts by weight of total weight of the raw material, other raw materials with effect of lowering blood sugar are
30~40 parts by weight of the raw material.
Complex microorganism is lactic acid bacteria and the mixture of saccharomycete.Wherein lactic acid bacteria includes:Lactobacillus plantarum, rhamnose breast
Bacillus and streptococcus thermophilus;Saccharomycete includes:Cr-enriched yeast and Se-enriched yeast.
Preferably, the additive amount of complex microorganism is 5~10 parts by weight of the total weight of the raw material, saccharomycete and lactic acid
The mass ratio of bacterium is 1:1, the mass ratio of Cr-enriched yeast and Se-enriched yeast is 3:1, lactobacillus plantarum, Lactobacillus rhamnosus and thermophilic
Streptococcic mass ratio is 2:1:3.
Another object of the present invention is to propose the preparation method of the seaweed ferment with function of blood sugar reduction, and technical solution is
It is achieved in that:
Step 1, pretreatment of raw material.By seaweed and other raw materials with effect of lowering blood sugar, including:Ginseng, pueraria lobata, the fruit of Chinese wolfberry,
Ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, corn stigma etc. are proportionally added into after carrying out the pretreatments such as washing and sterilizing.It will treat
The compound material stripping and slicing of processing adds water mill to be starched into compound seaweed.
Step 2 carries out one time fermentation to compound seaweed slurry described in step 1.Cr-enriched yeast is added in advance in compound seaweed slurry
And Se-enriched yeast, since saccharomycete is facultative anaerobic bacteria, oxygen in slurries can be consumed under certain condition and is gone forward side by side line splitting.It treats multiple
The oxygen closed in seaweed slurry is exhausted, and can add in anaerobic bacteria and carry out secondary fermentation.
Step 3 carries out secondary fermentation in compound seaweed slurry described in step 2.The Composite Milk of anaerobism is added in compound seaweed slurry
Sour bacterium, including lactobacillus plantarum, Lactobacillus rhamnosus and streptococcus thermophilus, mixing sealing is fermented under certain condition.It treats
PH stable no longer changes 3.0, is considered as fermentation ends.
Step 4, vacuum distillation, remove alcohol.Since step 3 carries out under anaerobic, and yeast under anaerobic
Bacterium fermentation can generate alcohol, it is necessary to be evaporated under reduced pressure to the seaweed ferment of composite fermentation, to remove alcohol.
Step 5, compounding.Step 4 gained seaweed ferment pH value is 3.0 or so, further, is promoted by adding cell-oligosaccharide
It is absorbed into other raw materials, addition fructose, maltitol improve mouthfeel, are easy to be accepted, the chromium as hypoglycemic suppression of addition pyridine carboxylic acid
Fat strengthens insulin active, and adds in VC, VE, lactalbumin etc. and improve immunity of organisms.
Step 6, filtering and impurity removing and canned.By canning sealing after the seaweed ferment homogeneous after compounding described in step 5, obtain most
The seaweed ferment of whole function of blood sugar reduction.
Preferably, above-mentioned raw material sterilization treatment is high temperature pasteurization, and the weight for adding water is 50 times of compound seaweed slurries
Weight.
Fermentation condition in step 2 is that temperature is 25-30 DEG C, when fermentation time is 8-12 small.
Fermentation condition in step 3 is that temperature is 37 DEG C of constant temperature, and fermentation time is 10 days or so, and pH stable is 3.0
No longer change.
Vacuum distillation condition in step 4 is that pressure is 0.1-0.2MPa, is heated to 40-45 DEG C, makes alcoholic strength≤0.5%.
After-ripening condition in step 5 is temperature for 37 DEG C of constant temperature, fermentation 90 days with up to pH to no longer changing.
The beneficial effects of the present invention are compared with prior art, the new technology that the present invention incorporates, advantage exists
In:
1st, the raw material of integration of drinking and medicinal herbs.The complication of hyperglycaemia is more, and hypoglycemic drug toxic side effect is big.The present invention is using seaweed to be main former
Material compounds a variety of Chinese medicine food elite with effect of lowering blood sugar including ginseng, pueraria lobata, the fruit of Chinese wolfberry and is formulated, no
Only it is that there is good effect of lowering blood sugar, and it is full of nutrition, comprehensive, and various raw materials cooperate, and mutually promote, and are with food
Medicine, with food for medicine, be both being rich in nutrition food and with life enhancement, prevent and cure diseases.Integration of drinking and medicinal herbs is recovered one's original simplicity.To changing
Kind improvement acidity system, prevention person in middle and old age's chronic disease also have certain effect.
2nd, composite bacteria.(1)Chromium is one of the essential trace elements of the human body, the metabolism of sugar is influenced by insulin, in machine
Special role is played in the glycometabolism and lipid metaboli of body.Inorganic chromium is transformed into Organic Chromium by Cr-enriched yeast by bioconversion, from
And chromium absorption rate in body is improved, its toxic side effect is reduced, it is preferably played and adjusts blood glucose, lipid-loweringing and norcholesterol
Effect.(2)Selenium can stimulate the generation of immunoglobulin, make the various immune functions of human body be improved.Diabetes patient's blood selenium
Significantly lower than the blood selenium of normal person.Selenium-supply can reduce blood glucose level, while increase the activity of GPX, stimulate on adipocyte plasma membrane
Glucan carrier transport process.In addition, activity of glutathione peroxidase is in extremely low level in diabetes patient's body, suffer from
The sick time is longer, and activity is lower, periodically takes Se-enriched yeast, can play the role of protecting pancreatic functions, be conducive to improve
Metabolism reduces the glucosylation hemoglobin level in urine.(3)Lactobacillus rhamnosus:Lactobacillus rhamnosus is resistant to animal
Digestive tract environment is colonized in humans and animals enteron aisle, is played and is adjusted intestinal flora, excludes toxin and improve the work(such as immunity of organisms
Effect.
3rd, two-step fermenting.Since lactic acid bacteria is anaerobic bacteria, for lactic acid bacteria is made more preferably to grow, shorten fermentation time, multiple
Close in seaweed slurry and add in Cr-enriched yeast and Se-enriched yeast in advance, make saccharomycete in slurries into line splitting to consume oxygen.Once
When the 8-12 that ferments is small, after the oxygen in seaweed ferment solution is exhausted by saccharomycete, lactobacillus plantarum, the sandlwood of anaerobism are added in
Sugared lactobacillus and streptococcus thermophilus carry out secondary fermentation, and fermentation time is 10 days or so, treats that pH stable no longer changes 3.0,
Obtain seaweed enzymolysis liquid.A variety of mushrooms used in the present invention have both the function of balance blood sugar blood fat, make it in assistance enzymolysis, promote
Macromolecular substances are decomposed into while be easily absorbed by the body the small-molecule substance utilized, strengthen the hypoglycemic work(of the raw materials such as seaweed
Energy.The fermentation process of sealing can reduce miscellaneous bacteria growth, and raw material has efficiently enough beneficial viable bacterias after ensureing pasteurization, promotes
Fermentation.
4th, the compounded formula of after-ripening.The seaweed ferment mouthfeel that pH value is 3.0 or so is sour and astringent, by adding fructose, maltose
Alcohol, cell-oligosaccharide, chromium picolinate, VC, VE, lactalbumin adjustment flavor, improve mouthfeel, are formed a kind of with effect of lowering blood sugar
And the excellent enzyme beverage of mouthfeel.
Specific embodiment
The present invention is further described with reference to specific embodiment, so that those skilled in the art knows more about
The present invention, but be not intended to limit the present invention.
Embodiment 1
New fresh seaweed, ginseng, pueraria lobata, the fruit of Chinese wolfberry, ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, corn stigma is taken to clean
It is miscellaneous, carry out pasteurize.
Seaweed 60g is added in, other raw materials press 1:1 ratio adds in common 40g.
Above-mentioned raw materials are shredded and adds in isometric pure water to wear into pulpous state spare;The weight ratio of raw material and water is 1:8.
Slurry feedstock is heated to 30 DEG C of holding constant temperature, 2.5g Cr-enriched yeasts is separately added into and Se-enriched yeast is once sent out
Ferment;
10 it is small when after add in 2g lactobacillus plantarums, 1g Lactobacillus rhamnosus and 3g streptococcus thermophilus, be heated to 37 DEG C of holding constant temperature
Secondary fermentation is carried out, ferment pH stable is measured after 10 days 3.0, obtains compound seaweed enzyme liquid, fermentation ends.
Seaweed ferment is decompressed to 0.1MPa and being heated to 40 DEG C makes alcohol evaporate into alcoholic strength=0.3%.
To removing alcohol after seaweed ferment in add in fructose, maltitol, cell-oligosaccharide, chromium picolinate, VC, VE,
Filtering and impurity removing is canned after lactalbumin keeps 10 DEG C, 100 days of constant temperature, obtains seaweed ferment.
The hypoglycemic zoopery of seaweed ferment in embodiment 1 is as follows:
Experimental subjects:Select 100 Kun Ming mices, dosage selection:Daily 0.5 × 10-3Gram, 1.2 × 10-3Gram, 2 × 10-3
Gram above-mentioned ferment gavage as experimental group 1,2,3 groups, blank group fills tap water, and every group is 25 small white mouses.
The female small white mouse of health is taken, average weight is 25 grams, when fasting 5 is small(But free water), take tail hematometry
Blood glucose value is randomly divided into 4 groups by blood glucose value level, respectively according to above-mentioned dosage gavage small white mouse, continuous gavage 20 days, fasting
5 it is small when after, take tail hematometry blood glucose value, observe the influence of tested small white mouse fasting blood-glucose and sugar tolerance.
Influence of the seaweed ferment to normal small white mouse fasting blood-glucose
Influence of the seaweed ferment to normal small white mouse sugar tolerance
P < 0.01 compared with the control group;
Experimental group 1,2,3 is can be seen that from the data in above table to compare with blank group, difference is extremely notable, it can be seen that,
Seaweed ferment can enhance the load sugar tolerance of normal small white mouse.
Embodiment 2
New fresh seaweed, ginseng, pueraria lobata, the fruit of Chinese wolfberry, ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, corn stigma is taken to clean
It is miscellaneous, carry out pasteurize.Seaweed 70g is added in, other raw materials press 1:1 ratio adds in common 30g.Above-mentioned raw materials are shredded and added in
It is spare that isometric pure water wears into pulpous state.
Slurry feedstock is heated to 30 DEG C of holding constant temperature, 4g Cr-enriched yeasts is separately added into and Se-enriched yeast carries out one time fermentation
10 it is small when after add in 2g lactobacillus plantarums, 1g Lactobacillus rhamnosus and 3g streptococcus thermophilus, be heated to 37 DEG C of holding constant temperature
Secondary fermentation is carried out, ferment pH stable is measured after 8 days 3.0, obtains compound seaweed enzyme liquid, fermentation ends.
Seaweed ferment is decompressed to 0.2MPa and being heated to 45 DEG C makes alcohol evaporate into alcoholic strength=0.3%.
To removing alcohol after seaweed ferment in add in fructose, maltitol, cell-oligosaccharide, chromium picolinate, VC, VE,
Filtering and impurity removing is canned after lactalbumin keeps 10 DEG C, 100 days of constant temperature.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
With within principle, any modifications, equivalent replacements and improvements are made should all be included in the protection scope of the present invention god.
Claims (9)
1. a kind of preparation method of the seaweed ferment with function of blood sugar reduction, comprises the following steps:
(1)It by seaweed and other raw material sterilization treatments with effect of lowering blood sugar, mixes in proportion, adds water mill into compound seaweed
Slurry;
Seaweed and other raw materials with effect of lowering blood sugar;
The parts by weight of seaweed are 60-70, and other raw materials with effect of lowering blood sugar are 30-40 parts;
(2)Saccharomycete, one time fermentation are added in compound seaweed is starched;
(3)Lactic acid bacteria, secondary fermentation are added in compound seaweed slurry;
(4)Vacuum distillation removes alcohol;
(5)Adding carbohydrate and vitamin;
The total weight of saccharomycete and lactic acid bacteria is 5-10 parts by weight, and the mass ratio of saccharomycete and lactic acid bacteria is 1:1.
2. a kind of preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that also wrap
Include step(6):Filtering and impurity removing is simultaneously canned.
A kind of 3. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
(1)In raw material sterilization treatment be high temperature pasteurization.
A kind of 4. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
(2)In saccharomycete be the Mixed Microbes of Cr-enriched yeast and Se-enriched yeast, the mass ratio of Cr-enriched yeast and Se-enriched yeast is 3:1.
A kind of 5. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
(2)Middle fermentation condition is that temperature is 25-30 DEG C, when fermentation time is 8-12 small,.
A kind of 6. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
(3)In lactic acid bacteria for lactobacillus plantarum, Lactobacillus rhamnosus and streptococcus thermophilus, fermentation condition is that temperature is 37 DEG C of constant temperature
, fermentation time is 10 days, and pH stable is 3.0.
A kind of 7. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
(4)In vacuum distillation condition be pressure for 0.1-0.2MPa, be heated to 40-45 DEG C, keep alcoholic strength≤0.5%.
8. a kind of preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that other
Raw material with effect of lowering blood sugar, including ginseng, pueraria lobata, the fruit of Chinese wolfberry, ganoderma lucidum, Rhizoma Atractylodis Macrocephalae, Radix Ophiopogonis, Typhonium flagelliforme (Lodd.) Blume, the coptis, Radix Astragali, jade
At least one of rice palpus.
A kind of 9. preparation method of the seaweed ferment with function of blood sugar reduction as described in claim 1, which is characterized in that step
5 be 37 DEG C of constant temperature, fermentation 90 days with up to pH to no longer changing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711216454.2A CN108056469A (en) | 2017-11-28 | 2017-11-28 | The preparation method of seaweed ferment with function of blood sugar reduction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711216454.2A CN108056469A (en) | 2017-11-28 | 2017-11-28 | The preparation method of seaweed ferment with function of blood sugar reduction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108056469A true CN108056469A (en) | 2018-05-22 |
Family
ID=62135110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711216454.2A Pending CN108056469A (en) | 2017-11-28 | 2017-11-28 | The preparation method of seaweed ferment with function of blood sugar reduction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108056469A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108902949A (en) * | 2018-07-30 | 2018-11-30 | 山东晨彰生物科技有限公司 | A kind of ferment and preparation method thereof with prevention gout function |
CN109349644A (en) * | 2018-10-30 | 2019-02-19 | 广州普维君健药业有限公司 | Probiotic composition, health food and its preparation method and application |
CN109601619A (en) * | 2018-10-31 | 2019-04-12 | 广州明为生物科技有限公司 | A kind of auxiliary hyperglycemic type lactic bacteria composition and the method for preparing sour milk beverage with it |
CN111035002A (en) * | 2020-01-16 | 2020-04-21 | 肽晟堂生物科技(常州)有限公司 | Preparation method of saponin rice enzyme |
CN111466503A (en) * | 2020-04-22 | 2020-07-31 | 江南大学 | Method for preparing selenium-rich enzyme beverage |
CN111772182A (en) * | 2020-07-21 | 2020-10-16 | 集美大学 | Seaweed ferment and preparation method thereof |
CN112998260A (en) * | 2021-04-14 | 2021-06-22 | 四川省食品发酵工业研究设计院有限公司 | Enzyme rich in high-activity enzyme and preparation method thereof |
CN113491331A (en) * | 2021-06-30 | 2021-10-12 | 华南理工大学 | Algal polysaccharide composition and composite fruit juice mixed fermentation powder as well as preparation method and application thereof |
CN114903154A (en) * | 2022-04-13 | 2022-08-16 | 山东筱萤生物科技有限公司 | Method for obtaining blood sugar-reducing type fermented seaweed product based on yeast-lactic acid bacteria step-by-step fermentation |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070071031A (en) * | 2005-12-29 | 2007-07-04 | 주식회사 삼양제넥스 | Low glycemic index composition containing tagatose |
CN104305207A (en) * | 2014-11-19 | 2015-01-28 | 上海世道健康科技有限公司 | Formula of traditional Chinese medicine composite ferment and preparing method thereof |
CN104705709A (en) * | 2015-04-07 | 2015-06-17 | 青岛海洋生物医药研究院股份有限公司 | Method for producing algae ferment through double-term fermentation |
CN105559064A (en) * | 2015-12-23 | 2016-05-11 | 于蜀豪 | Five-alga probiotic enzyme tablets and preparation method thereof |
CN105942490A (en) * | 2016-03-30 | 2016-09-21 | 北京森源华诚科技发展有限公司 | Compound enzyme composition for preventing and curing hyperlipidemia, hyperglycemia, and hypertension |
CN106578801A (en) * | 2016-12-13 | 2017-04-26 | 上海世道健康科技有限公司 | Comprehensive enzyme powder with hypoglycemic effect and preparation method thereof |
CN106822601A (en) * | 2017-02-07 | 2017-06-13 | 中山火炬职业技术学院 | A kind of dendrobium candidum ferment Ultramicro-powder and preparation method thereof |
CN106858579A (en) * | 2017-04-11 | 2017-06-20 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme for being applied to diabetes conditioning and routine servicing |
CN107183697A (en) * | 2017-07-22 | 2017-09-22 | 厦门元之道生物科技有限公司 | A kind of agaric sea-tangle enzyme liquid with effect for reducing blood fat and preparation method thereof |
-
2017
- 2017-11-28 CN CN201711216454.2A patent/CN108056469A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070071031A (en) * | 2005-12-29 | 2007-07-04 | 주식회사 삼양제넥스 | Low glycemic index composition containing tagatose |
CN104305207A (en) * | 2014-11-19 | 2015-01-28 | 上海世道健康科技有限公司 | Formula of traditional Chinese medicine composite ferment and preparing method thereof |
CN104705709A (en) * | 2015-04-07 | 2015-06-17 | 青岛海洋生物医药研究院股份有限公司 | Method for producing algae ferment through double-term fermentation |
CN105559064A (en) * | 2015-12-23 | 2016-05-11 | 于蜀豪 | Five-alga probiotic enzyme tablets and preparation method thereof |
CN105942490A (en) * | 2016-03-30 | 2016-09-21 | 北京森源华诚科技发展有限公司 | Compound enzyme composition for preventing and curing hyperlipidemia, hyperglycemia, and hypertension |
CN106578801A (en) * | 2016-12-13 | 2017-04-26 | 上海世道健康科技有限公司 | Comprehensive enzyme powder with hypoglycemic effect and preparation method thereof |
CN106822601A (en) * | 2017-02-07 | 2017-06-13 | 中山火炬职业技术学院 | A kind of dendrobium candidum ferment Ultramicro-powder and preparation method thereof |
CN106858579A (en) * | 2017-04-11 | 2017-06-20 | 姜红成 | Prepare the fermentation composition and preparation method of the plant enzyme for being applied to diabetes conditioning and routine servicing |
CN107183697A (en) * | 2017-07-22 | 2017-09-22 | 厦门元之道生物科技有限公司 | A kind of agaric sea-tangle enzyme liquid with effect for reducing blood fat and preparation method thereof |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108902949A (en) * | 2018-07-30 | 2018-11-30 | 山东晨彰生物科技有限公司 | A kind of ferment and preparation method thereof with prevention gout function |
CN109349644A (en) * | 2018-10-30 | 2019-02-19 | 广州普维君健药业有限公司 | Probiotic composition, health food and its preparation method and application |
CN109601619A (en) * | 2018-10-31 | 2019-04-12 | 广州明为生物科技有限公司 | A kind of auxiliary hyperglycemic type lactic bacteria composition and the method for preparing sour milk beverage with it |
CN111035002A (en) * | 2020-01-16 | 2020-04-21 | 肽晟堂生物科技(常州)有限公司 | Preparation method of saponin rice enzyme |
CN111466503A (en) * | 2020-04-22 | 2020-07-31 | 江南大学 | Method for preparing selenium-rich enzyme beverage |
CN111772182A (en) * | 2020-07-21 | 2020-10-16 | 集美大学 | Seaweed ferment and preparation method thereof |
CN112998260A (en) * | 2021-04-14 | 2021-06-22 | 四川省食品发酵工业研究设计院有限公司 | Enzyme rich in high-activity enzyme and preparation method thereof |
CN113491331A (en) * | 2021-06-30 | 2021-10-12 | 华南理工大学 | Algal polysaccharide composition and composite fruit juice mixed fermentation powder as well as preparation method and application thereof |
CN114903154A (en) * | 2022-04-13 | 2022-08-16 | 山东筱萤生物科技有限公司 | Method for obtaining blood sugar-reducing type fermented seaweed product based on yeast-lactic acid bacteria step-by-step fermentation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108056469A (en) | The preparation method of seaweed ferment with function of blood sugar reduction | |
CN106578805A (en) | Functional fruit and vegetable enzyme beverage | |
CN107232588A (en) | A kind of processing method of Noni fruit ferment | |
CN105249100B (en) | The production method of fermented fruits and vegetables juice and fermented glutinous rice beverage with compound functions | |
CN105053866B (en) | A kind of compound germ flour and preparation method thereof to relax bowel | |
CN105614774A (en) | Preparation method of fruit and vegetable active ferment liquid | |
CN107334099A (en) | Fruit ferment and preparation method thereof | |
CN108244432A (en) | A kind of fermentation Cordyceps militaris probiotic beverage and preparation method thereof | |
CN110916177B (en) | Method for preparing kelp enzyme by enzyme fermentation coupling technology | |
CN103431467B (en) | Asparagus extract bifidobacterium fermentation activity beverage and preparation method thereof | |
CN107028063A (en) | A kind of preparation method of RHIIZOMA DIOSCOREAE from Henan of China probiotic beverage | |
CN110169545A (en) | A method of fermentation duck is prepared using lactic acid bacteria | |
CN105919087A (en) | Compound fruit and vegetable enzymes and preparation method thereof | |
CN101756091B (en) | Pollen natto tablet | |
CN104522750A (en) | Alga healthcare food | |
CN104824773A (en) | Fresh sweet corn vinegar | |
CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
CN110122868B (en) | Stichopus japonicus enzyme, Stichopus japonicus enzyme beverage and preparation method | |
CN113142451A (en) | Chinese herbal medicine fermentation inoculant and preparation method of fermented Chinese herbal medicine beverage | |
CN108159291A (en) | Plant extracts and probiotics compounding product and preparation method thereof | |
CN106616945A (en) | Postbiotic and probiotic compound taking cordyceps adenosine as substrate and preparation method of postbiotic and probiotic compound | |
CN106213096A (en) | A kind of method that enzyme beverage prepared by Fructus Musae that ferments | |
CN107242350A (en) | A kind of selenium-rich lactobacillus preparation of degradable oxalic acid and preparation method and application | |
CN103653107A (en) | Preparation method of probiotic fermented kiwi fruit juice | |
CN109169899A (en) | A kind of preparation method of the shield stomach acidified milk containing Hericium erinaceus beta glucan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180522 |
|
RJ01 | Rejection of invention patent application after publication |